SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-077369
Filing Date
2022-12-02
Accepted
2022-12-02 17:00:54
Documents
13
Period of Report
2022-11-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea169540-8k_chinapharma.htm   iXBRL 8-K 28147
2 TECHNOLOGY TRANSFER CONTRACT, DATED NOVEMBER 28, 2022, BETWEEN HAINAN HELPSON ME ea169540ex10-1_chinapharma.htm EX-10.1 33781
  Complete submission text file 0001213900-22-077369.txt   243755

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cphi-20221128.xsd EX-101.SCH 3260
4 XBRL LABEL FILE cphi-20221128_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cphi-20221128_pre.xml EX-101.PRE 22381
7 EXTRACTED XBRL INSTANCE DOCUMENT ea169540-8k_chinapharma_htm.xml XML 3695
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 221442832
SIC: 2834 Pharmaceutical Preparations